<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33149115</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models.</ArticleTitle><Pagination><StartPage>5580</StartPage><MedlinePgn>5580</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-19396-3</ELocationID><Abstract><AbstractText>In a subgroup of patients with amyotrophic lateral sclerosis (ALS)/Frontotemporal dementia (FTD), the (G4C2)-RNA repeat expansion from C9orf72 chromosome binds to the Ran-activating protein (RanGAP) at the nuclear pore, resulting in nucleocytoplasmic transport deficit and accumulation of Ran in the cytosol. Here, we found that the sigma-1 receptor (Sig-1R), a molecular chaperone, reverses the pathological effects of (G4C2)-RNA repeats in cell lines and in Drosophila. The Sig-1R colocalizes with RanGAP and nuclear pore proteins (Nups) and stabilizes the latter. Interestingly, Sig-1Rs directly bind (G4C2)-RNA repeats. Overexpression of Sig-1Rs rescues, whereas the Sig-1R knockout exacerbates, the (G4C2)-RNA repeats-induced aberrant cytoplasmic accumulation of Ran. In Drosophila, Sig-1R (but not the Sig-1R-E102Q mutant) overexpression reverses eye necrosis, climbing deficit, and firing discharge caused by (G4C2)-RNA repeats. These results on a molecular chaperone at the nuclear pore suggest that Sig-1Rs may benefit patients with C9orf72 ALS/FTD by chaperoning the nuclear pore assembly and sponging away deleterious (G4C2)-RNA repeats.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Pin-Tse</ForeName><Initials>PT</Initials><Identifier Source="ORCID">0000-0002-8910-779X</Identifier><AffiliationInfo><Affiliation>Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, NIH, 333 Cassell Drive, Baltimore, MD, 21224, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Ph.D Program for Neural Regenerative Medicine, Taipei Medical University, 250 Wuxing Street, Taipei, 11031, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taiwan Biomaterial Company, 6F, No. 26-1, Sec. 2, Shengyi Rd., Zhubei City, Hsin-Chu County, 30261, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li&#xe9;vens</LastName><ForeName>Jean-Charles</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-0139-2291</Identifier><AffiliationInfo><Affiliation>MMDN, University of Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shao-Ming</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0003-1479-9100</Identifier><AffiliationInfo><Affiliation>Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, NIH, 333 Cassell Drive, Baltimore, MD, 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Jian-Ying</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0001-5124-0643</Identifier><AffiliationInfo><Affiliation>The Ph.D Program for Neural Regenerative Medicine, Taipei Medical University, 250 Wuxing Street, Taipei, 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Bilal</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7251-4340</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hsiang-En</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0003-4492-2077</Identifier><AffiliationInfo><Affiliation>Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, NIH, 333 Cassell Drive, Baltimore, MD, 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Wen-Chang</ForeName><Initials>WC</Initials><Identifier Source="ORCID">0000-0002-1801-553X</Identifier><AffiliationInfo><Affiliation>The Ph.D Program for Neural Regenerative Medicine, Taipei Medical University, 250 Wuxing Street, Taipei, 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurice</LastName><ForeName>Tangui</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4074-6793</Identifier><AffiliationInfo><Affiliation>MMDN, University of Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Tsung-Ping</ForeName><Initials>TP</Initials><Identifier Source="ORCID">0000-0003-2384-6925</Identifier><AffiliationInfo><Affiliation>Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, NIH, 333 Cassell Drive, Baltimore, MD, 21224, USA. TSU@intra.nida.nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017480">Receptors, sigma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C106106">sigma-1 receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020931">ran GTP-Binding Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003600" MajorTopicYN="N">Cytosol</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055786" MajorTopicYN="N">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022022" MajorTopicYN="N">Nuclear Pore</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017480" MajorTopicYN="N">Receptors, sigma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020931" MajorTopicYN="N">ran GTP-Binding Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33149115</ArticleId><ArticleId IdType="pmc">PMC7642387</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-19396-3</ArticleId><ArticleId IdType="pii">10.1038/s41467-020-19396-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, et al. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep. 2012;2:1016. doi: 10.1038/srep01016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01016</ArticleId><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S, et al. Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS. J. Cell Sci. 2015;128:1787&#x2013;1799. doi: 10.1242/jcs.165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165332</ArticleId><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattamatta A, Cleary JD, Ranum LPW. All in the family: repeats and ALS/FTD. Trends Neurosci. 2018;41:247&#x2013;250. doi: 10.1016/j.tins.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.03.010</ArticleId><ArticleId IdType="pmc">PMC5965280</ArticleId><ArticleId IdType="pubmed">29703376</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med. 2018;24:1136&#x2013;1142. doi: 10.1038/s41591-018-0071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, et al. In situ structure of neuronal C9orf72 Poly-GA aggregates reveals proteasome recruitment. Cell. 2018;172:696&#x2013;705. doi: 10.1016/j.cell.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.030</ArticleId><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. Stress granule assembly disrupts nucleocytoplasmic transport. Cell. 2018;173:958&#x2013;971. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira PA. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration. Cell Mol. Life Sci. 2019;76:2247&#x2013;2273. doi: 10.1007/s00018-019-03029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03029-0</ArticleId><ArticleId IdType="pmc">PMC6531325</ArticleId><ArticleId IdType="pubmed">30742233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoelz A, Glavy JS, Beck M. Toward the atomic structure of the nuclear pore complex: when top down meets bottom up. Nat. Struct. Mol. Biol. 2016;23:624&#x2013;630. doi: 10.1038/nsmb.3244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3244</ArticleId><ArticleId IdType="pmc">PMC5156573</ArticleId><ArticleId IdType="pubmed">27273515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DH, et al. Architecture of the symmetric core of the nuclear pore. Science. 2016;352:aaf1015. doi: 10.1126/science.aaf1015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1015</ArticleId><ArticleId IdType="pmc">PMC5207208</ArticleId><ArticleId IdType="pubmed">27081075</ArticleId></ArticleIdList></Reference><Reference><Citation>Su TP. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J. Pharmacol. Exp. Ther. 1982;223:284&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">6290634</ArticleId></ArticleIdList></Reference><Reference><Citation>Su TP, London ED, Jaffe JH. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science. 1988;240:219&#x2013;221. doi: 10.1126/science.2832949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2832949</ArticleId><ArticleId IdType="pubmed">2832949</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder SH, Largent BL. Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. J. Neuropsychiatry Clin. Neurosci. 1989;1:7&#x2013;15. doi: 10.1176/jnp.1.1.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.1.1.7</ArticleId><ArticleId IdType="pubmed">2577720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellewell SB, Bowen WD. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 1990;527:244&#x2013;253. doi: 10.1016/0006-8993(90)91143-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(90)91143-5</ArticleId><ArticleId IdType="pubmed">2174717</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurice T, Su TP, Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 1998;83:413&#x2013;428. doi: 10.1016/S0306-4522(97)00405-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(97)00405-3</ArticleId><ArticleId IdType="pubmed">9460750</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Hajipour AR, Sievert MK, Arbabian M, Ruoho AE. Characterization of the cocaine binding site on the sigma-1 receptor. Biochemistry. 2007;46:3532&#x2013;3542. doi: 10.1021/bi061727o.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi061727o</ArticleId><ArticleId IdType="pubmed">17315983</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanilla D, et al. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009;323:934&#x2013;937. doi: 10.1126/science.1166127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166127</ArticleId><ArticleId IdType="pmc">PMC2947205</ArticleId><ArticleId IdType="pubmed">19213917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong WC, et al. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. J. Biol. Chem. 2017;292:11250&#x2013;11261. doi: 10.1074/jbc.M116.774075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.774075</ArticleId><ArticleId IdType="pmc">PMC5500793</ArticleId><ArticleId IdType="pubmed">28495886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambo DO, et al. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat. Commun. 2017;8:2228. doi: 10.1038/s41467-017-02087-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02087-x</ArticleId><ArticleId IdType="pmc">PMC5738444</ArticleId><ArticleId IdType="pubmed">29263318</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HR, et al. Crystal structure of the human sigma1 receptor. Nature. 2016;532:527&#x2013;530. doi: 10.1038/nature17391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17391</ArticleId><ArticleId IdType="pmc">PMC5550834</ArticleId><ArticleId IdType="pubmed">27042935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell. 2007;131:596&#x2013;610. doi: 10.1016/j.cell.2007.08.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.036</ArticleId><ArticleId IdType="pubmed">17981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Bowen WD. Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells. J. Biol. Chem. 2008;283:28198&#x2013;28215. doi: 10.1074/jbc.M802099200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802099200</ArticleId><ArticleId IdType="pmc">PMC2661391</ArticleId><ArticleId IdType="pubmed">18539593</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddings CR, et al. Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor. Neurobiol. Dis. 2019;129:118&#x2013;129. doi: 10.1016/j.nbd.2019.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.05.009</ArticleId><ArticleId IdType="pmc">PMC6996243</ArticleId><ArticleId IdType="pubmed">31108174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Saul A, Roon P, Smith SB. Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration. Proc. Natl Acad. Sci. USA. 2016;113:E3764&#x2013;E3772. doi: 10.1073/pnas.1521749113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1521749113</ArticleId><ArticleId IdType="pmc">PMC4932934</ArticleId><ArticleId IdType="pubmed">27298364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu A, et al. Targeting the sigma-1 receptor via pridopidine ameliorates central features of ALS pathology in a SOD1(G93A) model. Cell Death Dis. 2019;10:210. doi: 10.1038/s41419-019-1451-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1451-2</ArticleId><ArticleId IdType="pmc">PMC6397200</ArticleId><ArticleId IdType="pubmed">30824685</ArticleId></ArticleIdList></Reference><Reference><Citation>Francardo V, et al. Pridopidine induces functional neurorestoration via the sigma-1 receptor in a mouse model of Parkinson&#x2019;s disease. Neurotherapeutics. 2019;16:465&#x2013;479. doi: 10.1007/s13311-018-00699-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-00699-9</ArticleId><ArticleId IdType="pmc">PMC6554374</ArticleId><ArticleId IdType="pubmed">30756361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryskamp D, et al. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. Neurobiol. Dis. 2017;97:46&#x2013;59. doi: 10.1016/j.nbd.2016.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.10.006</ArticleId><ArticleId IdType="pmc">PMC5214572</ArticleId><ArticleId IdType="pubmed">27818324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. The molecular chaperone sigma 1 receptor mediates rescue of retinal cone photoreceptor cells via modulation of NRF2. Free Radic. Biol. Med. 2019;134:604&#x2013;616. doi: 10.1016/j.freeradbiomed.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.02.001</ArticleId><ArticleId IdType="pmc">PMC6619428</ArticleId><ArticleId IdType="pubmed">30743048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryskamp D, et al. Pridopidine stabilizes mushroom spines in mouse models of Alzheimer&#x2019;s disease by acting on the sigma-1 receptor. Neurobiol. Dis. 2019;124:489&#x2013;504. doi: 10.1016/j.nbd.2018.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.12.022</ArticleId><ArticleId IdType="pmc">PMC6363865</ArticleId><ArticleId IdType="pubmed">30594810</ArticleId></ArticleIdList></Reference><Reference><Citation>Su TP, Su TC, Nakamura Y, Tsai SY. The Sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol. Sci. 2016;37:262&#x2013;278. doi: 10.1016/j.tips.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2016.01.003</ArticleId><ArticleId IdType="pmc">PMC4811735</ArticleId><ArticleId IdType="pubmed">26869505</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, et al. Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody. Neuroscience. 2016;331:148&#x2013;157. doi: 10.1016/j.neuroscience.2016.06.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.06.030</ArticleId><ArticleId IdType="pmc">PMC5047027</ArticleId><ArticleId IdType="pubmed">27339730</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, Epstein M, Guo LW. Subcellular localization of the sigma-1 receptor in retinal neurons - an electron microscopy study. Sci. Rep. 2015;5:10689. doi: 10.1038/srep10689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10689</ArticleId><ArticleId IdType="pmc">PMC4649997</ArticleId><ArticleId IdType="pubmed">26033680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, et al. APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. Oncotarget. 2017;8:51317&#x2013;51330. doi: 10.18632/oncotarget.17906.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.17906</ArticleId><ArticleId IdType="pmc">PMC5584251</ArticleId><ArticleId IdType="pubmed">28881650</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai SY, et al. Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope. Proc. Natl Acad. Sci. USA. 2015;112:E6562&#x2013;E6570. doi: 10.1073/pnas.1518894112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1518894112</ArticleId><ArticleId IdType="pmc">PMC4664336</ArticleId><ArticleId IdType="pubmed">26554014</ArticleId></ArticleIdList></Reference><Reference><Citation>Luty AA, et al. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann. Neurol. 2010;68:639&#x2013;649. doi: 10.1002/ana.22274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22274</ArticleId><ArticleId IdType="pubmed">21031579</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A, Al-Mohanna F, Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 2011;70:913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Marissal N, Medard JJ, Azzedine H, Chrast R. Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. Brain. 2015;138:875&#x2013;890. doi: 10.1093/brain/awv008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv008</ArticleId><ArticleId IdType="pubmed">25678561</ArticleId></ArticleIdList></Reference><Reference><Citation>Couly S, et al. Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2020;29:529&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">31696229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, et al. Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N&#x2019;-dimethyltryptamine forming enzyme, indole-N-methyl transferase. Neuroscience. 2012;206:60&#x2013;68. doi: 10.1016/j.neuroscience.2011.12.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.12.040</ArticleId><ArticleId IdType="pmc">PMC3321351</ArticleId><ArticleId IdType="pubmed">22265729</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, et al. Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience. 2013;240:129&#x2013;134. doi: 10.1016/j.neuroscience.2013.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.02.035</ArticleId><ArticleId IdType="pmc">PMC3665351</ArticleId><ArticleId IdType="pubmed">23458708</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggett CJ, et al. Development and characterisation of a glutamate-sensitive motor neurone cell line. J. Neurochem. 2000;74:1895&#x2013;1902. doi: 10.1046/j.1471-4159.2000.0741895.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2000.0741895.x</ArticleId><ArticleId IdType="pubmed">10800932</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ, Eggett CJ. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J. Neurol. 2000;247:I17&#x2013;I27. doi: 10.1007/BF03161151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03161151</ArticleId><ArticleId IdType="pubmed">10795883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T, Hayashi T, Hayashi E, Su TP. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS ONE. 2013;8:e76941. doi: 10.1371/journal.pone.0076941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076941</ArticleId><ArticleId IdType="pmc">PMC3799859</ArticleId><ArticleId IdType="pubmed">24204710</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer CP, Mahen R, Schnell E, Djamgoz MB, Aydar E. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res. 2007;67:11166&#x2013;11175. doi: 10.1158/0008-5472.CAN-07-1771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-07-1771</ArticleId><ArticleId IdType="pubmed">18056441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruoho AE, et al. The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. Curr. Pharm. Des. 2012;18:920&#x2013;929. doi: 10.2174/138161212799436584.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161212799436584</ArticleId><ArticleId IdType="pmc">PMC4440231</ArticleId><ArticleId IdType="pubmed">22288412</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuva-Aydemir Y, Almeida S, Gao FB. Insights into C9ORF72-related ALS/FTD from Drosophila and iPSC models. Trends Neurosci. 2018;41:457&#x2013;469. doi: 10.1016/j.tins.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.04.002</ArticleId><ArticleId IdType="pmc">PMC6015541</ArticleId><ArticleId IdType="pubmed">29729808</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc. Natl Acad. Sci. USA. 2013;110:7778&#x2013;7783. doi: 10.1073/pnas.1219643110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219643110</ArticleId><ArticleId IdType="pmc">PMC3651485</ArticleId><ArticleId IdType="pubmed">23553836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuebler D, Tanouye MA. Modifications of seizure susceptibility in Drosophila. J. Neurophysiol. 2000;83:998&#x2013;1009. doi: 10.1152/jn.2000.83.2.998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2000.83.2.998</ArticleId><ArticleId IdType="pubmed">10669511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Wu CF. Electroconvulsive seizure behavior in Drosophila: analysis of the physiological repertoire underlying a stereotyped action pattern in bang-sensitive mutants. J. Neurosci. 2002;22:11065&#x2013;11079. doi: 10.1523/JNEUROSCI.22-24-11065.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-24-11065.2002</ArticleId><ArticleId IdType="pmc">PMC6758420</ArticleId><ArticleId IdType="pubmed">12486202</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Lagier-Tourenne C. Nuclear pores: the gate to neurodegeneration. Nat. Neurosci. 2018;21:156&#x2013;158. doi: 10.1038/s41593-017-0066-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0066-0</ArticleId><ArticleId IdType="pubmed">29371653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourrich S, et al. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell. 2013;152:236&#x2013;247. doi: 10.1016/j.cell.2012.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.12.004</ArticleId><ArticleId IdType="pmc">PMC4159768</ArticleId><ArticleId IdType="pubmed">23332758</ArticleId></ArticleIdList></Reference><Reference><Citation>Takebayashi M, Hayashi T, Su TP. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants. J. Pharmacol. Exp. Ther. 2002;303:1227&#x2013;1237. doi: 10.1124/jpet.102.041970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.102.041970</ArticleId><ArticleId IdType="pubmed">12438547</ArticleId></ArticleIdList></Reference><Reference><Citation>Omi T, et al. Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor. Cell Death Dis. 2014;5:e1332. doi: 10.1038/cddis.2014.301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.301</ArticleId><ArticleId IdType="pmc">PMC4123092</ArticleId><ArticleId IdType="pubmed">25032855</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DY, et al. Sigma-1 receptor activation alleviates blood-brain barrier dysfunction in vascular dementia mice. Exp. Neurol. 2018;308:90&#x2013;99. doi: 10.1016/j.expneurol.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.07.002</ArticleId><ArticleId IdType="pubmed">30006137</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X. et al. Chronic stimulation of the Sigma-1 receptor ameliorates autonomic nerve dysfunction and atrial fibrillation susceptibility in rat models of depression. Am. J. Physiol. Heart Circ. Physiol.315, H1521&#x2013;H1531 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30216117</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M, et al. Nuclear pore complex structure and dynamics revealed by cryoelectron tomography. Science. 2004;306:1387&#x2013;1390. doi: 10.1126/science.1104808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1104808</ArticleId><ArticleId IdType="pubmed">15514115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampmann M, Blobel G. Three-dimensional structure and flexibility of a membrane-coating module of the nuclear pore complex. Nat. Struct. Mol. Biol. 2009;16:782&#x2013;788. doi: 10.1038/nsmb.1618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1618</ArticleId><ArticleId IdType="pmc">PMC2706296</ArticleId><ArticleId IdType="pubmed">19503077</ArticleId></ArticleIdList></Reference><Reference><Citation>Amlacher S, et al. Insight into structure and assembly of the nuclear pore complex by utilizing the genome of a eukaryotic thermophile. Cell. 2011;146:277&#x2013;289. doi: 10.1016/j.cell.2011.06.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.06.039</ArticleId><ArticleId IdType="pubmed">21784248</ArticleId></ArticleIdList></Reference><Reference><Citation>Fyfe I. APOE*epsilon4 - a risk factor for TDP43 pathology? Nat. Rev. Neurol. 2018;14:570&#x2013;571. doi: 10.1038/s41582-018-0064-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0064-1</ArticleId><ArticleId IdType="pubmed">30120349</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT, et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171:615&#x2013;627. doi: 10.1016/j.cell.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.08.048</ArticleId><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki Y, et al. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases. Neuropathology. 2014;34:148&#x2013;158. doi: 10.1111/neup.12080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12080</ArticleId><ArticleId IdType="pubmed">24313828</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki Y, Tanji K, Mori F, Wakabayashi K. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington&#x2019;s disease. Neurobiol. Dis. 2015;74:25&#x2013;31. doi: 10.1016/j.nbd.2014.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.11.005</ArticleId><ArticleId IdType="pubmed">25449906</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345:1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeene L, et al. An ALS case with 38 (G4C2)-repeats in the C9orf72 gene shows TDP-43 and sparse dipeptide repeat protein pathology. Acta Neuropathol. 2019;137:855&#x2013;858. doi: 10.1007/s00401-019-01996-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01996-z</ArticleId><ArticleId IdType="pubmed">30919029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T, Su TP. Intracellular dynamics of &#x3c3;-1 receptors (&#x3c3;1 binding sites) in NG108-15 cells. J. Pharmacol. Exp. Ther. 2003;306:726&#x2013;733. doi: 10.1124/jpet.103.051292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.103.051292</ArticleId><ArticleId IdType="pubmed">12730356</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T, Su TP. Sigma-1 receptors at galactosylceremide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc. Natl Acad. Sci. USA. 2004;101:14949&#x2013;14954. doi: 10.1073/pnas.0402890101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402890101</ArticleId><ArticleId IdType="pmc">PMC522002</ArticleId><ArticleId IdType="pubmed">15466698</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>